This company has been marked as potentially delisted and may not be actively trading. CAMP4 Therapeutics (CAMP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CAMP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Cantor Fitzgerald Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight RecommendationOctober 3, 2025 | msn.comCamp4 Therapeutics initiated with an Overweight at Cantor FitzgeraldOctober 2, 2025 | msn.comCAMP4 Initiates GLP Toxicology Studies for CMP-SYNGAP-01October 1, 2025 | tipranks.comCAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 in SYNGAP1-Related DisordersOctober 1, 2025 | quiverquant.comQCAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01October 1, 2025 | globenewswire.comCamp4 Therapeutics (CAMP) Price Target Decreased by 18.18% to 9.18September 30, 2025 | msn.comCamp4 Therapeutics (CAMP) sees $4.5 million investment from 5AM Ventures VII, L.P.September 16, 2025 | investing.comCamp4 Therapeutics downgraded to Neutral from Overweight at JPMorganSeptember 16, 2025 | msn.comCamp4 Therapeutics price target lowered to $12 from $18 at Piper SandlerSeptember 15, 2025 | msn.comNashat Amir buys Camp4 Therapeutics (CAMP) shares worth $1.99mSeptember 12, 2025 | investing.comMajor Investments Pour into CAMP4 Therapeutics Corporation!September 11, 2025 | tipranks.comCamp4 Therapeutics announces oversubscribed private placement up to $100MSeptember 10, 2025 | msn.comCAMP4 Therapeutics Shares Triple After Securing $100M Private PlacementSeptember 10, 2025 | msn.comCAMP4 Therapeutics stock soars after $100 million private placementSeptember 10, 2025 | za.investing.comCAMP4 Therapeutics Secures $100M in Private PlacementSeptember 10, 2025 | tipranks.comCAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related DisordersSeptember 10, 2025 | globenewswire.comCAMP4 Therapeutics Reports Q2 2025 Progress and OutlookAugust 27, 2025 | tipranks.comCamp4 Therapeutics reports Q2 EPS (62c), consensus (67c)August 14, 2025 | msn.comCAMP4 Reports Second Quarter 2025 Financial Results and Corporate HighlightsAugust 14, 2025 | globenewswire.comCAMP4 Therapeutics Corporation Common Stock (CAMP)July 14, 2025 | nasdaq.comCan Camp4 Therapeutics (NASDAQ:CAMP) Afford To Invest In Growth?June 28, 2025 | finance.yahoo.comUrea Cycle Disorders Market to Register Sustainable Growth During the Study Period (2020–2034) | DelveInsightJune 20, 2025 | finance.yahoo.comWedbush Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform RecommendationMay 27, 2025 | msn.comCAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual MeetingMay 16, 2025 | globenewswire.comCAMP4 Reports First Quarter 2025 Financial Results and Corporate HighlightsMay 13, 2025 | globenewswire.comCAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual MeetingApril 28, 2025 | globenewswire.comUPDATE - CalAmp Announces Headquarters Relocation to Carlsbad, CA to Streamline Operations and Strengthen Technical HubMarch 28, 2025 | markets.businessinsider.comCAMP4 Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comCAMP4 Appoints Multiple Industry Veterans to its Board of DirectorsMarch 18, 2025 | globenewswire.comCORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025March 13, 2025 | globenewswire.comCalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025March 13, 2025 | globenewswire.comCalAmp Welcomes Thomas Polan as Product Director for Student Safety Business UnitMarch 1, 2025 | finance.yahoo.comCAMP4 to Participate in Upcoming Investor ConferencesFebruary 6, 2025 | globenewswire.comCAMP4 Provides Corporate Updates and Highlights Key Upcoming MilestonesJanuary 7, 2025 | globenewswire.comCAMP4 to Participate in the Piper Sandler 36th Annual Healthcare ConferenceDecember 2, 2024 | globenewswire.comCAMP4 Reports Third Quarter 2024 Financial ResultsNovember 21, 2024 | globenewswire.comWilliam Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform RecommendationNovember 7, 2024 | msn.comCAMP4 Analyst Highlights Rare Disease Platform PotentialNovember 5, 2024 | benzinga.comCamp4 Therapeutics initiated with an Outperform at LeerinkNovember 5, 2024 | markets.businessinsider.comCamp4 Therapeutics initiated with an Overweight at Piper SandlerNovember 5, 2024 | markets.businessinsider.comCAMP4 Announces Pricing of Initial Public OfferingOctober 10, 2024 | globenewswire.comCalAmp Industrial IoT Gateway Named an OEM Off-Highway 2024 Top New Product Award RecipientSeptember 24, 2024 | globenewswire.comCampina Ice Cream Industry Tbk PT (CAMP)August 30, 2024 | investing.comCalAmp Welcomes Thomas Ayers as General Manager of Edge Device BusinessAugust 29, 2024 | globenewswire.comCalAmp Launches Inventory Manager for Seamless Device DeploymentsAugust 6, 2024 | globenewswire.comLynrock Lake Takes CalAmp PrivateAugust 1, 2024 | globenewswire.comCalAmp Announces Appointment of Paul Washicko as Senior Vice President of Product ManagementJuly 9, 2024 | globenewswire.comCalAmp Announces General Availability of HMU3640LB Industrial GatewayJune 20, 2024 | globenewswire.comCalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial RestructuringJune 3, 2024 | globenewswire.comCalAmp Enhances School Bus Solutions Suite with Dispatch MonitorMay 1, 2024 | globenewswire.com Get CAMP4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CAMP Media Mentions By Week CAMP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CAMP News Sentiment▼0.000.77▲Average Medical News Sentiment CAMP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CAMP Articles This Week▼11▲CAMP Articles Average Week Get the Latest News and Ratings for CAMP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CAMP4 Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies KVHI News Today CMTL News Today AWRE News Today CSCO News Today QCOM News Today PANW News Today MSI News Today SATS News Today CIEN News Today FFIV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CAMP) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion int...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAMP4 Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CAMP4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
